Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a)

Abstract

Regular aspirin use was associated with significantly lower ASCVD mortality in adults without clinical ASCVD who had elevated Lp(a). These findings may have clinical and public health implications for aspirin utilization in primary prevention.